Response to Osimertinib in an EGFR Exon 20 Insertion-Positive Lung Adenocarcinoma

J Thorac Oncol. 2018 Oct;13(10):e204-e206. doi: 10.1016/j.jtho.2018.05.017.
No abstract available

Publication types

  • Letter

MeSH terms

  • Acrylamides / pharmacology
  • Acrylamides / therapeutic use*
  • Adenocarcinoma of Lung / drug therapy*
  • Adenocarcinoma of Lung / pathology
  • Aged, 80 and over
  • Aniline Compounds / pharmacology
  • Aniline Compounds / therapeutic use*
  • Antineoplastic Agents / pharmacology
  • Antineoplastic Agents / therapeutic use*
  • ErbB Receptors / genetics
  • Exons
  • Female
  • Humans

Substances

  • Acrylamides
  • Aniline Compounds
  • Antineoplastic Agents
  • osimertinib
  • EGFR protein, human
  • ErbB Receptors